SynthesisAnnals of medicine2026

Efficacy and safety of Ruxolitinib-based combination therapy in the patients with Myelofibrosis (MF): a systematic review and meta-analysis.

Shuai Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.